SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-028548
Filing Date
2021-05-18
Accepted
2021-05-18 08:21:24
Documents
6
Period of Report
2021-05-18

Document Format Files

Seq Description Document Type Size
1 6-K Q1 2021 mito-6k_20210518.htm 6-K 25696
2 EX-10.1 mito-ex101_9.htm EX-10.1 38836
3 EX-10.2 mito-ex102_26.htm EX-10.2 81749
4 EX-99.1 mito-ex991_10.htm EX-99.1 9982
5 EX-99.2 mito-ex992_6.htm EX-99.2 175094
6 GRAPHIC gwunewgnt1ch000001.jpg GRAPHIC 4800
  Complete submission text file 0001564590-21-028548.txt   339157
Mailing Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005
Business Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005 617-600-6888
Stealth BioTherapeutics Corp (Filer) CIK: 0001696396 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38810 | Film No.: 21933945
SIC: 2834 Pharmaceutical Preparations